Author: Tim Gunn

Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change.

Chemotherapy-induced peripheral neuropathy is caused by cancer treatment, but doctors don’t have a way to treat it. Our research is changing that.

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It’s now an approved treatment for them in England and Scotland.

Teenagers and young adults with cancer have to deal with unique challenges. We’re using our expertise to help tackle them.

Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England. 

We’re helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

Cancer Research UK today announced the appointments of Rakshit Kapoor and Hitesh Thakrar to its Council of Trustees, the charity’s board of directors.

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we’re going to stop it.